|Articles|August 1, 2016
- Pharmaceutical Executive-08-01-2016
- Volume 36
- Issue 8
Pharmaceutical Executive, August 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Pharm Exec's 15th Annual Industry Auditabout 9 years ago
The Industry Audit: Fifteen Years Rightabout 9 years ago
Dealmaking in 2016: It’s Complicatedabout 9 years ago
Steady Hands: AmerisourceBergen's Peyton Howellabout 9 years ago
Drug Shortages Raise Economic and Ethical Challengesabout 9 years ago
The ‘Cure’-All for 21st Century Data Sharingover 9 years ago
European Pharma and the Unified Patent Courtover 9 years ago
An EU Referendum ... on Drug Pricing?over 9 years ago
Country Report: HungaryNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Sends Amended Acquisition Proposal to Metsera
2
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
3
FDA Approves Kygevvi Becoming the First Treatment for Thymidine Kinase 2 Deficiency
4
Roundup: Pharma Industry Forms Strategic Collaborations Bolstering Research and Development Pipelines for Autoimmune and Oncology Therapies
5
